Steve S Cho1,2, Ryan Zeh1, John T Pierce1, Jun Jeon1,2, MacLean Nasrallah3, Nithin D Adappa4, James N Palmer4, Jason G Newman4, Caitlin White5, Julia Kharlip5, Peter Snyder5, Philip Low6, Sunil Singhal7, M Sean Grady1, John Y K Lee1. 1. Department of Neurosurgery, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania. 2. Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania. 3. Department of Pathology, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania. 4. Department of Otorhinolaryngology, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania. 5. Department of Endocrinology, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania. 6. Department of Biochemistry, Purdue University, West Lafayette, Indiana. 7. Department of Surgery, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania.
Abstract
BACKGROUND: Surgical resection is the primary treatment for nonfunctional (NF) pituitary adenomas, but gross-total resection is difficult to achieve in all cases. NF adenomas overexpress folate receptor alpha (FRα). OBJECTIVE: To test the hypothesis that we could target FRα for highly sensitive and specific intraoperative detection of NF adenomas using near-infrared (NIR) imaging. METHODS: Fourteen patients with NF pituitary adenoma were infused with the folate analog NIR dye OTL38 preoperatively. NIR fluorescence signal-to-background ratio (SBR) was recorded for each tumor during resection of the adenomas. Extent of surgery was not modified based on the presence or absence of fluorescence. Immunohistochemistry was performed to assess FRα expression in all specimens. Magnetic resonance imaging (MRI) was performed postoperatively to assess residual neoplasm. RESULTS: Nine adenomas overexpressed FRα and fluoresced with a NIR SBR of 3.2 ± 0.52, whereas the 5 non-FRα-overexpressing adenomas fluoresced with an SBR of 1.5 ± 0.21. Linear regression demonstrated a significant correlation between intraoperative SBR and the FRα expression (P-value < .001). Analysis of 14 margin samples revealed that the surgeon's impression of the tissue had 83% sensitivity, 100% specificity, 100% positive predictive value, and 89% negative predictive value, while NIR fluorescence had 100% for all values. NIR fluorescence accurately predicted postoperative MRI results in 78% of FRα-overexpressing patients. CONCLUSION: Preoperative injection of folate-tagged NIR dye provides strong signal and visualization of NF pituitary adenomas. It is 100% sensitive and specific for detecting margin neoplasm and can predict postoperative MRI findings. Our results suggest that NIR fluorescence may be superior to white-light visualization alone and may improve resection rates in NF pituitary adenomas.
BACKGROUND: Surgical resection is the primary treatment for nonfunctional (NF) pituitary adenomas, but gross-total resection is difficult to achieve in all cases. NF adenomas overexpress folate receptor alpha (FRα). OBJECTIVE: To test the hypothesis that we could target FRα for highly sensitive and specific intraoperative detection of NF adenomas using near-infrared (NIR) imaging. METHODS: Fourteen patients with NF pituitary adenoma were infused with the folate analog NIR dye OTL38 preoperatively. NIR fluorescence signal-to-background ratio (SBR) was recorded for each tumor during resection of the adenomas. Extent of surgery was not modified based on the presence or absence of fluorescence. Immunohistochemistry was performed to assess FRα expression in all specimens. Magnetic resonance imaging (MRI) was performed postoperatively to assess residual neoplasm. RESULTS: Nine adenomas overexpressed FRα and fluoresced with a NIR SBR of 3.2 ± 0.52, whereas the 5 non-FRα-overexpressing adenomas fluoresced with an SBR of 1.5 ± 0.21. Linear regression demonstrated a significant correlation between intraoperative SBR and the FRα expression (P-value < .001). Analysis of 14 margin samples revealed that the surgeon's impression of the tissue had 83% sensitivity, 100% specificity, 100% positive predictive value, and 89% negative predictive value, while NIR fluorescence had 100% for all values. NIR fluorescence accurately predicted postoperative MRI results in 78% of FRα-overexpressing patients. CONCLUSION: Preoperative injection of folate-tagged NIR dye provides strong signal and visualization of NF pituitary adenomas. It is 100% sensitive and specific for detecting margin neoplasm and can predict postoperative MRI findings. Our results suggest that NIR fluorescence may be superior to white-light visualization alone and may improve resection rates in NF pituitary adenomas.
Authors: John S Kuo; Garni Barkhoudarian; Christopher J Farrell; Mary E Bodach; Luis M Tumialan; Nelson M Oyesiku; Zachary Litvack; Gabriel Zada; Chirag G Patil; Manish K Aghi Journal: Neurosurgery Date: 2016-10 Impact factor: 4.654
Authors: John Y K Lee; John T Pierce; Jayesh P Thawani; Ryan Zeh; Shuming Nie; Maria Martinez-Lage; Sunil Singhal Journal: J Neurosurg Date: 2017-04-07 Impact factor: 5.115
Authors: Mohamed Ahmed Labib; Daniel M Prevedello; Juan C Fernandez-Miranda; Sanan Sivakanthan; Arnau Benet; Victor Morera; Ricardo Carrau; Amin Kassam Journal: Neurosurgery Date: 2013-03 Impact factor: 4.654
Authors: John Y K Lee; John T Pierce; Ryan Zeh; Steve S Cho; Ryan Salinas; Shuming Nie; Sunil Singhal Journal: World Neurosurg Date: 2017-06-30 Impact factor: 2.104
Authors: John Y K Lee; Steve S Cho; Ryan Zeh; John T Pierce; Maria Martinez-Lage; Nithin D Adappa; James N Palmer; Jason G Newman; Kim O Learned; Caitlin White; Julia Kharlip; Peter Snyder; Philip S Low; Sunil Singhal; M Sean Grady Journal: J Neurosurg Date: 2017-08-25 Impact factor: 5.115
Authors: John Y K Lee; Jayesh P Thawani; John Pierce; Ryan Zeh; Maria Martinez-Lage; Michelle Chanin; Ollin Venegas; Sarah Nims; Kim Learned; Jane Keating; Sunil Singhal Journal: Neurosurgery Date: 2016-12 Impact factor: 4.654
Authors: Gooitzen M van Dam; George Themelis; Lucia M A Crane; Niels J Harlaar; Rick G Pleijhuis; Wendy Kelder; Athanasios Sarantopoulos; Johannes S de Jong; Henriette J G Arts; Ate G J van der Zee; Joost Bart; Philip S Low; Vasilis Ntziachristos Journal: Nat Med Date: 2011-09-18 Impact factor: 53.440
Authors: Jun W Jeon; Steve S Cho; Shayoni Nag; Love Buch; John Pierce; YouRong S Su; Nithin D Adappa; James N Palmer; Jason G Newman; Sunil Singhal; John Y K Lee Journal: Oper Neurosurg (Hagerstown) Date: 2019-07-01 Impact factor: 2.703
Authors: Alexander Micko; Fabian Placzek; Roger Fonollà; Michael Winklehner; Ryan Sentosa; Arno Krause; Greisa Vila; Romana Höftberger; Marco Andreana; Wolfgang Drexler; Rainer A Leitgeb; Angelika Unterhuber; Stefan Wolfsberger Journal: Front Endocrinol (Lausanne) Date: 2021-10-18 Impact factor: 5.555
Authors: Servando Hernandez Vargas; Christie Lin; Hop S Tran Cao; Naruhiko Ikoma; Solmaz AghaAmiri; Sukhen C Ghosh; Adam J Uselmann; Ali Azhdarinia Journal: Front Oncol Date: 2021-06-30 Impact factor: 6.244